Article
Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy.
AIDS (London, England) - 2 Jan 2010
Paredes Roger, Cheng Irene, Kuritzkes Daniel R, Tuomala Ruth E
Abstract excerpt
BACKGROUND: Pregnancy-limited antiretroviral therapy (PLAT) drastically reduces HIV-1 transmission to the newborn, but may select for antiretroviral drug resistance mutations in mothers. METHODS: We evaluated antiretroviral-naive, HIV-1-infected pregnant women who received PLAT between 1998 and 2005, and had 2-month or 6-month postpartum plasma samples available with HIV-1 RNA levels more than 500 copies/ml....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.